Evidence map›Paper›PMID 33231721›Full record

ArticleCellular and molecular life sciences : CMLS2021

Aquaporin-3 is involved in NLRP3-inflammasome activation contributing to the setting of inflammatory response.

Inês Vieira da Silva, Carlos Cardoso, Helios Martínez-Banaclocha, Angela Casini, Pablo Pelegrín, Graça Soveral

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. AQP3 and AQP9-Contrary Players in Sepsis?International journal of molecular sciences · 2024
    Article
  13. Aquaporin Expression and Regulation in Clinical and Experimental Sepsis.International journal of molecular sciences · 2023
    Review
  14. Current research trends of nanomedicines.Acta pharmaceutica Sinica. B · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Aquaporins in Immune System.Advances in experimental medicine and biology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Inês Vieira da SilvaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
Carlos CardosoDepartment of Biochemistry and Human Biology, Faculty of Pharmacy, Universidade de Lisboa, 1649-003, Lisboa, Portugal.
Helios Martínez-BanaclochaMolecular Inflammation Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), Hospital Clínico Universitario Virgen de La Arrixaca, Carretera Buenavista, 30120, Murcia, Spain.
Angela CasiniDepartment of Chemistry, Technical University of Munich, Lichtenbergstr. 4, 85748, Garching b. München, Germany.
Pablo Pelegrín *Molecular Inflammation Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), Hospital Clínico Universitario Virgen de La Arrixaca, Carretera Buenavista, 30120, Murcia, Spain. pablo.pelegrin@imib.es.
Graça Soveral *Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal. gsoveral@ff.ulisboa.pt.ORCID http://orcid.org/0000-0001-8487-110X
University of Lisbon · PTInstituto Murciano de Investigación Biosanitaria · ESTechnical University of Munich · DE

Funding

European Cooperation in Science and Technology EU COST Action BM1406Fundação para a Ciência e a Tecnologia PD/BD/113634/2015Fundação para a Ciência e a Tecnologia PTDC/BTM-SAL/28977/2017Fundação para a Ciência e a Tecnologia UID/DTP/04138/2019Fundación Séneca 20859/PI/18H2020 European Research Council ERC-2013-CoG grant 614578Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2017-88276-R
6 · The paper itself

Abstract

Inflammasomes are large immune multiprotein complexes that tightly regulate the production of the pro-inflammatory cytokines, being dependent on cell regulatory volume mechanisms. Aquaporins (AQPs) are protein channels that facilitate the transport of water and glycerol (aquaglyceroporins) through membranes, essential for cell volume regulation. Although these membrane proteins are highly expressed in monocytes and macrophages, their role in the inflammatory process is still unclear. Here, we investigated the role of aquaglyceroporin AQP3 in NLRP3-inflammasome activation by complementary approaches based either on shRNA silencing or on AQP3 selective inhibition. The latter has been achieved using a reported potent gold-based inhibitor, Auphen. AQP3 inhibition or silencing partially blocked LPS-priming and decreased production of IL-6, proIL-1β, and TNF-α, suggesting the possible involvement of AQP3 in macrophage priming by Toll-like receptor 4 engagement. Moreover, AQP3-dependent cell reswelling increased IL-1β release through caspase-1 activation. NLRP3-inflammasome activation induced by reswelling, nigericin, and ATP was also blocked when AQP3 was inhibited or silenced. Altogether, these data point towards AQPs as potential players in the setting of the inflammatory response.

Indexed as

Aquaporin 3Caspase 1Cell LineCytokinesGlycerolHumansInflammasomesInterleukin-1betaLipopolysaccharidesMacrophagesNigericinNLR Family, Pyrin Domain-Containing 3 ProteinOrganogold CompoundsPotassiumRNA InterferenceRNA, Small InterferingAquaporin 3Caspase 1Cytokinesdichloro(phenanthroline)gold(III)GlycerolInflammasomesInterleukin-1betaLipopolysaccharidesNigericinNLR Family, Pyrin Domain-Containing 3 ProteinOrganogold CompoundsPotassiumRNA, Small InterferingToll-Like Receptor 4AquaglyceroporinInflammasomeInflammationInterleukin-1MacrophagesWater and glycerol permeability

Identifiers

PMID33231721
PMCPMC11073090
OpenAlexW3108875450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.